array(40) {
  [0]=>
  string(4) "1758"
  ["article_id"]=>
  string(4) "1758"
  [1]=>
  string(106) "Amgen Makes All Repatha (evolocumab) Device Options Available In The US At A 60 Percent Reduced List Price"
  ["article_title"]=>
  string(106) "Amgen Makes All Repatha (evolocumab) Device Options Available In The US At A 60 Percent Reduced List Price"
  [2]=>
  string(150) "THOUSAND OAKS, Calif., Jan. 7, 2019 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that as part of the Company's commitment to improve patien"
  ["short_description"]=>
  string(150) "THOUSAND OAKS, Calif., Jan. 7, 2019 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that as part of the Company's commitment to improve patien"
  [3]=>
  string(248) "THOUSAND OAKS, Calif., Jan. 7, 2019 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that as part of the Company's commitment to improve patient affordability for an innovative biologic medicine for people with high cholesterol who are at..."
  ["description"]=>
  string(248) "THOUSAND OAKS, Calif., Jan. 7, 2019 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that as part of the Company's commitment to improve patient affordability for an innovative biologic medicine for people with high cholesterol who are at..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "15"
  ["rss_id"]=>
  string(2) "15"
  [14]=>
  string(295) "https://www.drugs.com/clinical_trials/amgen-makes-all-repatha-evolocumab-device-options-available-us-60-percent-reduced-list-price-18059.html?utm_source=ddc&utm_medium=rss&utm_campaign=Amgen+Makes+All+Repatha+%28evolocumab%29+Device+Options+Available+In+The+US+At+A+60+Percent+Reduced+List+Price"
  ["blog_url"]=>
  string(295) "https://www.drugs.com/clinical_trials/amgen-makes-all-repatha-evolocumab-device-options-available-us-60-percent-reduced-list-price-18059.html?utm_source=ddc&utm_medium=rss&utm_campaign=Amgen+Makes+All+Repatha+%28evolocumab%29+Device+Options+Available+In+The+US+At+A+60+Percent+Reduced+List+Price"
  [15]=>
  string(19) "2019-01-08 04:01:17"
  ["add_date"]=>
  string(19) "2019-01-08 04:01:17"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-02-15 20:39:38"
  ["create_at"]=>
  string(19) "2019-02-15 20:39:38"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "1556"
  ["article_id"]=>
  string(4) "1556"
  [1]=>
  string(33) "Career progression within the NHS"
  ["article_title"]=>
  string(33) "Career progression within the NHS"
  [2]=>
  string(150) "With roles opening up for pharmacists in urgent care settings, hospitals and primary care, new opportunities are being created for pharmacists looking"
  ["short_description"]=>
  string(150) "With roles opening up for pharmacists in urgent care settings, hospitals and primary care, new opportunities are being created for pharmacists looking"
  [3]=>
  string(173) "With roles opening up for pharmacists in urgent care settings, hospitals and primary care, new opportunities are being created for pharmacists looking to move up in the NHS."
  ["description"]=>
  string(173) "With roles opening up for pharmacists in urgent care settings, hospitals and primary care, new opportunities are being created for pharmacists looking to move up in the NHS."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "12"
  ["rss_id"]=>
  string(2) "12"
  [14]=>
  string(138) "https://www.pharmaceutical-journal.com/careers-and-jobs/careers-and-jobs/career-feature/career-progression-within-the-nhs/20205331.article"
  ["blog_url"]=>
  string(138) "https://www.pharmaceutical-journal.com/careers-and-jobs/careers-and-jobs/career-feature/career-progression-within-the-nhs/20205331.article"
  [15]=>
  string(19) "2019-01-07 20:07:00"
  ["add_date"]=>
  string(19) "2019-01-07 20:07:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-01-15 18:25:22"
  ["create_at"]=>
  string(19) "2019-01-15 18:25:22"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "4567"
  ["article_id"]=>
  string(4) "4567"
  [1]=>
  string(40) "FDA Approval Process for Medical Devices"
  ["article_title"]=>
  string(40) "FDA Approval Process for Medical Devices"
  [2]=>
  string(156) "Course overview&#nl&#nlThis seminar will provide a solid foundation in the approval and clearance processes for medical devices in the United States. Partic"
  ["short_description"]=>
  string(156) "Course overview&#nl&#nlThis seminar will provide a solid foundation in the approval and clearance processes for medical devices in the United States. Partic"
  [3]=>
  string(518) "Course overview&#nl&#nlThis seminar will provide a solid foundation in the approval and clearance processes for medical devices in the United States. Participants will gain an understanding of the underlying legal and regulatory requirements and the “general controls” applicable to all devices, including device classification, establishment registration and device listing. With the underlying framework in mind, the approval and clearance processes for new and modified devices will be presented, inc..."
  ["description"]=>
  string(518) "Course overview&#nl&#nlThis seminar will provide a solid foundation in the approval and clearance processes for medical devices in the United States. Participants will gain an understanding of the underlying legal and regulatory requirements and the “general controls” applicable to all devices, including device classification, establishment registration and device listing. With the underlying framework in mind, the approval and clearance processes for new and modified devices will be presented, inc..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "3"
  ["category"]=>
  string(1) "3"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "58"
  ["rss_id"]=>
  string(2) "58"
  [14]=>
  string(72) "https://www.pharmiweb.com/event/fda-approval-process-for-medical-devices"
  ["blog_url"]=>
  string(72) "https://www.pharmiweb.com/event/fda-approval-process-for-medical-devices"
  [15]=>
  string(19) "2019-01-07 19:54:34"
  ["add_date"]=>
  string(19) "2019-01-07 19:54:34"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-09-14 14:32:22"
  ["create_at"]=>
  string(19) "2019-09-14 14:32:22"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "4582"
  ["article_id"]=>
  string(4) "4582"
  [1]=>
  string(44) "Pharmacovigilance / GCP Audit Report Writing"
  ["article_title"]=>
  string(44) "Pharmacovigilance / GCP Audit Report Writing"
  [2]=>
  string(156) "Course overview&#nl&#nlAudits form an important part of the Pharmacovigilance (PV) and Good Clinical Practice (GCP) quality management systems, and the repo"
  ["short_description"]=>
  string(156) "Course overview&#nl&#nlAudits form an important part of the Pharmacovigilance (PV) and Good Clinical Practice (GCP) quality management systems, and the repo"
  [3]=>
  string(512) "Course overview&#nl&#nlAudits form an important part of the Pharmacovigilance (PV) and Good Clinical Practice (GCP) quality management systems, and the reports generated provide valuable information to assist companies with maintaining compliance. The audit report is required in GVP Module IV and is a crucial document in communicating compliance risks.&#nl&#nlThe course will cover the basic principles of how to communicate throughout the conduct of a PV/GCP audit, culminating in the preparation of the fi..."
  ["description"]=>
  string(512) "Course overview&#nl&#nlAudits form an important part of the Pharmacovigilance (PV) and Good Clinical Practice (GCP) quality management systems, and the reports generated provide valuable information to assist companies with maintaining compliance. The audit report is required in GVP Module IV and is a crucial document in communicating compliance risks.&#nl&#nlThe course will cover the basic principles of how to communicate throughout the conduct of a PV/GCP audit, culminating in the preparation of the fi..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "3"
  ["category"]=>
  string(1) "3"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "58"
  ["rss_id"]=>
  string(2) "58"
  [14]=>
  string(74) "https://www.pharmiweb.com/event/pharmacovigilance-gcp-audit-report-writing"
  ["blog_url"]=>
  string(74) "https://www.pharmiweb.com/event/pharmacovigilance-gcp-audit-report-writing"
  [15]=>
  string(19) "2019-01-07 19:50:32"
  ["add_date"]=>
  string(19) "2019-01-07 19:50:32"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-09-14 14:32:22"
  ["create_at"]=>
  string(19) "2019-09-14 14:32:22"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "4853"
  ["article_id"]=>
  string(4) "4853"
  [1]=>
  string(17) "ICH GCP Refresher"
  ["article_title"]=>
  string(17) "ICH GCP Refresher"
  [2]=>
  string(150) "This course offers a thorough update of the current understanding and interpretation of Good Clinical Practice and practical guidance/advice on how to"
  ["short_description"]=>
  string(150) "This course offers a thorough update of the current understanding and interpretation of Good Clinical Practice and practical guidance/advice on how to"
  [3]=>
  string(241) "This course offers a thorough update of the current understanding and interpretation of Good Clinical Practice and practical guidance/advice on how to ensure readiness for Health Authority inspections, both of Sponsor and Investigator sites."
  ["description"]=>
  string(241) "This course offers a thorough update of the current understanding and interpretation of Good Clinical Practice and practical guidance/advice on how to ensure readiness for Health Authority inspections, both of Sponsor and Investigator sites."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "3"
  ["category"]=>
  string(1) "3"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "58"
  ["rss_id"]=>
  string(2) "58"
  [14]=>
  string(49) "https://www.pharmiweb.com/event/ich-gcp-refresher"
  ["blog_url"]=>
  string(49) "https://www.pharmiweb.com/event/ich-gcp-refresher"
  [15]=>
  string(19) "2019-01-07 18:40:48"
  ["add_date"]=>
  string(19) "2019-01-07 18:40:48"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-09-27 14:12:07"
  ["create_at"]=>
  string(19) "2019-09-27 14:12:07"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "4874"
  ["article_id"]=>
  string(4) "4874"
  [1]=>
  string(38) "Project Management for Clinical Trials"
  ["article_title"]=>
  string(38) "Project Management for Clinical Trials"
  [2]=>
  string(150) "The aim of this workshop is to ensure you gain a comprehensive understanding of the tools and techniques of project management and how they can be app"
  ["short_description"]=>
  string(150) "The aim of this workshop is to ensure you gain a comprehensive understanding of the tools and techniques of project management and how they can be app"
  [3]=>
  string(517) "The aim of this workshop is to ensure you gain a comprehensive understanding of the tools and techniques of project management and how they can be applied straight away to your own clinical research projects in the work place.The detailed aims are to:• Understand technical project management tools and techniques and apply these to your work• Examine the competencies appropriate for an effective project manager• Identify the project critical path and use this information to assist in planning..."
  ["description"]=>
  string(517) "The aim of this workshop is to ensure you gain a comprehensive understanding of the tools and techniques of project management and how they can be applied straight away to your own clinical research projects in the work place.The detailed aims are to:• Understand technical project management tools and techniques and apply these to your work• Examine the competencies appropriate for an effective project manager• Identify the project critical path and use this information to assist in planning..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "3"
  ["category"]=>
  string(1) "3"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "58"
  ["rss_id"]=>
  string(2) "58"
  [14]=>
  string(70) "https://www.pharmiweb.com/event/project-management-for-clinical-trials"
  ["blog_url"]=>
  string(70) "https://www.pharmiweb.com/event/project-management-for-clinical-trials"
  [15]=>
  string(19) "2019-01-07 18:31:41"
  ["add_date"]=>
  string(19) "2019-01-07 18:31:41"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-09-27 14:12:08"
  ["create_at"]=>
  string(19) "2019-09-27 14:12:08"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "4550"
  ["article_id"]=>
  string(4) "4550"
  [1]=>
  string(64) "52nd World Nursing Leadership & Healthcare Management Conference"
  ["article_title"]=>
  string(64) "52nd World Nursing Leadership & Healthcare Management Conference"
  [2]=>
  string(150) "Following the Overwhelming success of our previous conferences, we are delighted to announce International Nursing and  Healthcare Congress held durin"
  ["short_description"]=>
  string(150) "Following the Overwhelming success of our previous conferences, we are delighted to announce International Nursing and  Healthcare Congress held durin"
  [3]=>
  string(513) "Following the Overwhelming success of our previous conferences, we are delighted to announce International Nursing and  Healthcare Congress held during September 23-24 , 2019 at Copenhagen, Denmark. The main theme of our conference is "Exploring Innovations and Modern Advancements in Nursing & Healthcare". Nursing Leadership 2019 aim is to bring leading Nurses, Clinical nurse specialists, Nurse practitioners, Young inspired researchers, Associate Professors and Scholars together to share..."
  ["description"]=>
  string(513) "Following the Overwhelming success of our previous conferences, we are delighted to announce International Nursing and  Healthcare Congress held during September 23-24 , 2019 at Copenhagen, Denmark. The main theme of our conference is "Exploring Innovations and Modern Advancements in Nursing & Healthcare". Nursing Leadership 2019 aim is to bring leading Nurses, Clinical nurse specialists, Nurse practitioners, Young inspired researchers, Associate Professors and Scholars together to share..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "3"
  ["category"]=>
  string(1) "3"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "58"
  ["rss_id"]=>
  string(2) "58"
  [14]=>
  string(94) "https://www.pharmiweb.com/event/52nd-world-nursing-leadership-healthcare-management-conference"
  ["blog_url"]=>
  string(94) "https://www.pharmiweb.com/event/52nd-world-nursing-leadership-healthcare-management-conference"
  [15]=>
  string(19) "2019-01-07 18:04:33"
  ["add_date"]=>
  string(19) "2019-01-07 18:04:33"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-09-14 14:32:21"
  ["create_at"]=>
  string(19) "2019-09-14 14:32:21"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "1853"
  ["article_id"]=>
  string(4) "1853"
  [1]=>
  string(124) "PAREXEL Introduces New Dedicated Division to Help Emerging Biotech Companies Reach their Goals Quickly and Cost-Effectively "
  ["article_title"]=>
  string(124) "PAREXEL Introduces New Dedicated Division to Help Emerging Biotech Companies Reach their Goals Quickly and Cost-Effectively "
  [2]=>
  string(150) "BOSTON, January 7, 2019 – PAREXEL International Corporation, a leading innovator of global biopharmaceutical services, today introduced a new, d"
  ["short_description"]=>
  string(150) "BOSTON, January 7, 2019 – PAREXEL International Corporation, a leading innovator of global biopharmaceutical services, today introduced a new, d"
  [3]=>
  string(626) "BOSTON, January 7, 2019 – PAREXEL International Corporation, a leading innovator of global biopharmaceutical services, today introduced a new, dedicated division to support emerging biotech companies in reaching their drug development and commercialization goals quickly and cost-effectively. PAREXEL Biotech builds on the Company’s heritage of clinical, regulatory, commercial and technology expertise with enhanced strategic consulting and asset development capabilities, offering a new Biotech-focused team and organizational structure for customers. Led by James Anthony, Global Head...&#nl&#nlSource: RealWire"
  ["description"]=>
  string(626) "BOSTON, January 7, 2019 – PAREXEL International Corporation, a leading innovator of global biopharmaceutical services, today introduced a new, dedicated division to support emerging biotech companies in reaching their drug development and commercialization goals quickly and cost-effectively. PAREXEL Biotech builds on the Company’s heritage of clinical, regulatory, commercial and technology expertise with enhanced strategic consulting and asset development capabilities, offering a new Biotech-focused team and organizational structure for customers. Led by James Anthony, Global Head...&#nl&#nlSource: RealWire"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "64"
  ["rss_id"]=>
  string(2) "64"
  [14]=>
  string(109) "http://www.realwire.com/releases/PAREXEL-Introduces-New-Dedicated-Division-to-Help-Emerging-Biotech-Companies"
  ["blog_url"]=>
  string(109) "http://www.realwire.com/releases/PAREXEL-Introduces-New-Dedicated-Division-to-Help-Emerging-Biotech-Companies"
  [15]=>
  string(19) "2019-01-07 17:41:00"
  ["add_date"]=>
  string(19) "2019-01-07 17:41:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-04-22 13:42:54"
  ["create_at"]=>
  string(19) "2019-04-22 13:42:54"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "5250"
  ["article_id"]=>
  string(4) "5250"
  [1]=>
  string(81) "From Molecule to Medicines - An Introduction to Clinical Trials including ICH-GCP"
  ["article_title"]=>
  string(81) "From Molecule to Medicines - An Introduction to Clinical Trials including ICH-GCP"
  [2]=>
  string(150) "Highly interactive course with a balance of information, workshops, exercises and quizzes offering a general overview of the drug development process "
  ["short_description"]=>
  string(150) "Highly interactive course with a balance of information, workshops, exercises and quizzes offering a general overview of the drug development process "
  [3]=>
  string(506) "Highly interactive course with a balance of information, workshops, exercises and quizzes offering a general overview of the drug development process including relevant tasks and responsibilities within the clinical research setting.&#nlIt provides details on how drugs are developed and who the key players in the process are, about the terminology used in the clinical research environment and what rules, guidelines and laws are essential.&#nlHow a clinical study is set up and performed and how to h..."
  ["description"]=>
  string(506) "Highly interactive course with a balance of information, workshops, exercises and quizzes offering a general overview of the drug development process including relevant tasks and responsibilities within the clinical research setting.&#nlIt provides details on how drugs are developed and who the key players in the process are, about the terminology used in the clinical research environment and what rules, guidelines and laws are essential.&#nlHow a clinical study is set up and performed and how to h..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "3"
  ["category"]=>
  string(1) "3"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "58"
  ["rss_id"]=>
  string(2) "58"
  [14]=>
  string(111) "https://www.pharmiweb.com/event/from-molecule-to-medicines-an-introduction-to-clinical-trials-including-ich-gcp"
  ["blog_url"]=>
  string(111) "https://www.pharmiweb.com/event/from-molecule-to-medicines-an-introduction-to-clinical-trials-including-ich-gcp"
  [15]=>
  string(19) "2019-01-07 17:01:52"
  ["add_date"]=>
  string(19) "2019-01-07 17:01:52"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-10-31 15:50:27"
  ["create_at"]=>
  string(19) "2019-10-31 15:50:27"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "5273"
  ["article_id"]=>
  string(4) "5273"
  [1]=>
  string(27) "Basics in Clinical Research"
  ["article_title"]=>
  string(27) "Basics in Clinical Research"
  [2]=>
  string(150) "The course offers a general overview of the drug development process and most relevant tasks and responsibilities within the clinical research setting"
  ["short_description"]=>
  string(150) "The course offers a general overview of the drug development process and most relevant tasks and responsibilities within the clinical research setting"
  [3]=>
  string(501) "The course offers a general overview of the drug development process and most relevant tasks and responsibilities within the clinical research setting, focusing on practical aspects and mainly addressing the needs of assistants and support personnel&#nlIt provides details on how drugs are developed, who the key players in the process are, terminology used, essential rules, guidelines and laws as well as information on clinical studies and documentation required in clinical research.&#nl "
  ["description"]=>
  string(501) "The course offers a general overview of the drug development process and most relevant tasks and responsibilities within the clinical research setting, focusing on practical aspects and mainly addressing the needs of assistants and support personnel&#nlIt provides details on how drugs are developed, who the key players in the process are, terminology used, essential rules, guidelines and laws as well as information on clinical studies and documentation required in clinical research.&#nl "
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "3"
  ["category"]=>
  string(1) "3"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "58"
  ["rss_id"]=>
  string(2) "58"
  [14]=>
  string(59) "https://www.pharmiweb.com/event/basics-in-clinical-research"
  ["blog_url"]=>
  string(59) "https://www.pharmiweb.com/event/basics-in-clinical-research"
  [15]=>
  string(19) "2019-01-07 09:22:26"
  ["add_date"]=>
  string(19) "2019-01-07 09:22:26"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-10-31 15:50:27"
  ["create_at"]=>
  string(19) "2019-10-31 15:50:27"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "1561"
  ["article_id"]=>
  string(4) "1561"
  [1]=>
  string(153) "Pfizer Initiates Phase 2b/3 Clinical Trial for PF-06651600, an Oral JAK3 Inhibitor, for the Treatment of Patients with Moderate to Severe Alopecia Areata"
  ["article_title"]=>
  string(153) "Pfizer Initiates Phase 2b/3 Clinical Trial for PF-06651600, an Oral JAK3 Inhibitor, for the Treatment of Patients with Moderate to Severe Alopecia Areata"
  [2]=>
  string(150) "January 3, 2019 -- Pfizer Inc. (NYSE: PFE) announced today the initiation of a Phase 2b/3 clinical trial for its oral JAK3 inhibitor, PF-06651600, for"
  ["short_description"]=>
  string(150) "January 3, 2019 -- Pfizer Inc. (NYSE: PFE) announced today the initiation of a Phase 2b/3 clinical trial for its oral JAK3 inhibitor, PF-06651600, for"
  [3]=>
  string(246) "January 3, 2019 -- Pfizer Inc. (NYSE: PFE) announced today the initiation of a Phase 2b/3 clinical trial for its oral JAK3 inhibitor, PF-06651600, for the treatment of patients with moderate to severe alopecia areata, a chronic autoimmune skin..."
  ["description"]=>
  string(246) "January 3, 2019 -- Pfizer Inc. (NYSE: PFE) announced today the initiation of a Phase 2b/3 clinical trial for its oral JAK3 inhibitor, PF-06651600, for the treatment of patients with moderate to severe alopecia areata, a chronic autoimmune skin..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "15"
  ["rss_id"]=>
  string(2) "15"
  [14]=>
  string(300) "https://www.drugs.com/clinical_trials/pfizer-initiates-phase-2b-3-clinical-trial-pf-06651600-oral-jak3-inhibitor-patients-moderate-severe-18045.html?utm_source=ddc&utm_medium=rss&utm_campaign=Pfizer+Initiates+Phase+2b%2F3+Clinical+Trial+for+PF-06651600%2C+an+Oral+JAK3+Inhibitor%2C+for+the+Treatment+"
  ["blog_url"]=>
  string(300) "https://www.drugs.com/clinical_trials/pfizer-initiates-phase-2b-3-clinical-trial-pf-06651600-oral-jak3-inhibitor-patients-moderate-severe-18045.html?utm_source=ddc&utm_medium=rss&utm_campaign=Pfizer+Initiates+Phase+2b%2F3+Clinical+Trial+for+PF-06651600%2C+an+Oral+JAK3+Inhibitor%2C+for+the+Treatment+"
  [15]=>
  string(19) "2019-01-05 08:01:13"
  ["add_date"]=>
  string(19) "2019-01-05 08:01:13"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-01-15 18:25:23"
  ["create_at"]=>
  string(19) "2019-01-15 18:25:23"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "1562"
  ["article_id"]=>
  string(4) "1562"
  [1]=>
  string(153) "Reata Announces Clinical Trial Design for FALCON, a Phase 3 Trial of Bardoxolone Methyl for the Treatment of Autosomal Dominant Polycystic Kidney Disease"
  ["article_title"]=>
  string(153) "Reata Announces Clinical Trial Design for FALCON, a Phase 3 Trial of Bardoxolone Methyl for the Treatment of Autosomal Dominant Polycystic Kidney Disease"
  [2]=>
  string(150) "IRVING, Texas, Jan. 03, 2019 (GLOBE NEWSWIRE) -- Reata Pharmaceuticals, Inc. (Nasdaq: RETA), a clinical-stage biopharmaceutical company, today announc"
  ["short_description"]=>
  string(150) "IRVING, Texas, Jan. 03, 2019 (GLOBE NEWSWIRE) -- Reata Pharmaceuticals, Inc. (Nasdaq: RETA), a clinical-stage biopharmaceutical company, today announc"
  [3]=>
  string(250) "IRVING, Texas, Jan. 03, 2019 (GLOBE NEWSWIRE) -- Reata Pharmaceuticals, Inc. (Nasdaq: RETA), a clinical-stage biopharmaceutical company, today announced that it has completed a successful end-of-Phase 2 meeting with the United States Food and Drug..."
  ["description"]=>
  string(250) "IRVING, Texas, Jan. 03, 2019 (GLOBE NEWSWIRE) -- Reata Pharmaceuticals, Inc. (Nasdaq: RETA), a clinical-stage biopharmaceutical company, today announced that it has completed a successful end-of-Phase 2 meeting with the United States Food and Drug..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "15"
  ["rss_id"]=>
  string(2) "15"
  [14]=>
  string(300) "https://www.drugs.com/clinical_trials/reata-announces-clinical-trial-design-falcon-phase-3-trial-bardoxolone-methyl-autosomal-dominant-18047.html?utm_source=ddc&utm_medium=rss&utm_campaign=Reata+Announces+Clinical+Trial+Design+for+FALCON%2C+a+Phase+3+Trial+of+Bardoxolone+Methyl+for+the+Treatment+of+"
  ["blog_url"]=>
  string(300) "https://www.drugs.com/clinical_trials/reata-announces-clinical-trial-design-falcon-phase-3-trial-bardoxolone-methyl-autosomal-dominant-18047.html?utm_source=ddc&utm_medium=rss&utm_campaign=Reata+Announces+Clinical+Trial+Design+for+FALCON%2C+a+Phase+3+Trial+of+Bardoxolone+Methyl+for+the+Treatment+of+"
  [15]=>
  string(19) "2019-01-05 08:01:11"
  ["add_date"]=>
  string(19) "2019-01-05 08:01:11"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-01-15 18:25:23"
  ["create_at"]=>
  string(19) "2019-01-15 18:25:23"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}